Suppr超能文献

CXCL8调节M0巨噬细胞的增殖和极化,以影响宫颈癌的肿瘤进展。

CXCL8 modulates M0 macrophage proliferation and polarization to influence tumor progression in cervical cancer.

作者信息

Zhao Xiyan, Yang Li, Pan Jigang, Zeng Zhirui, Zhang Tuo, Yang Yushi, Zhang Jingjing, Chen Tengxiang, Xiao Ziwen, Pan Wei

机构信息

Prenatal Diagnosis Center in Guizhou Province, The Affiliated Hospital of Guizhou Medical University, Guizhou, Guiyang, 550009, China.

Guizhou Institute of Precision Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang, 550009, China.

出版信息

Sci Rep. 2025 Jan 4;15(1):790. doi: 10.1038/s41598-024-81726-y.

Abstract

Cervical cancer (CESC) presents significant clinical challenges due to its complex tumor microenvironment (TME) and varied treatment responses. This study identified undifferentiated M0 macrophages as high-risk immune cells critically involved in CESC progression. Co-culture experiments further demonstrated that M0 macrophages significantly promoted HeLa cell proliferation, migration, and invasion, underscoring their pivotal role in modulating tumor cell behavior within the TME. A nine-gene prognostic model constructed from immune gene signatures highlighted CXCL8 as a key regulator of M0 macrophage behavior. Functional experiments demonstrated that CXCL8 knockdown in M0 macrophages inhibited their proliferation, shifted polarization toward an M1-dominant phenotype, and reduced tumor-promoting M2 polarization. Co-culture experiments with CXCL8-deficient M0 macrophages further revealed a suppression of HeLa cell proliferation, migration, and invasion. These findings position M0 macrophages as central regulators within the TME and suggest that targeting pathways like CXCL8 could provide novel therapeutic strategies for improving outcomes in CESC patients.

摘要

宫颈癌(CESC)因其复杂的肿瘤微环境(TME)和多样的治疗反应而呈现出重大的临床挑战。本研究确定未分化的M0巨噬细胞是参与CESC进展的关键高危免疫细胞。共培养实验进一步表明,M0巨噬细胞显著促进HeLa细胞的增殖、迁移和侵袭,突显了它们在调节TME内肿瘤细胞行为中的关键作用。由免疫基因特征构建的九基因预后模型突出显示CXCL8是M0巨噬细胞行为的关键调节因子。功能实验表明,M0巨噬细胞中CXCL8的敲低抑制了它们的增殖,使极化向以M1为主的表型转变,并减少了促肿瘤的M2极化。与缺乏CXCL8的M0巨噬细胞进行的共培养实验进一步揭示了对HeLa细胞增殖、迁移和侵袭的抑制作用。这些发现将M0巨噬细胞定位为TME内的核心调节因子,并表明靶向CXCL8等途径可为改善CESC患者的预后提供新的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9557/11700176/e0fa473ec0ae/41598_2024_81726_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验